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Abstract 
 
 Cancer is one of the most prevalent and deadly diseases worldwide despite the development 
of an abundance of therapies in the last several decades. Recently, focus has turned to cancer 
prevention to help mitigate the morbidity of the disease and thus identification of mechanisms that 
initiate tumorigenesis is of utmost importance. Chromosomal instability is known to be a driver of 
tumorigenesis and creates vast diversity within the same tumor, allowing for selection and clonal 
expansion of cells with oncogenic karyotypes. Centrosome amplification is one of the main 
mechanisms that induces chromosomal instability and does so by creating aberrant attachments to 
chromosomes during mitosis which often leads to chromosome missegregation. Recent work has 
identified centriole elongation as a cause of centriole amplification through fragmentation and 
ectopic procentriole formation, however, how centrioles regulate their length is poorly understood. 
One proposed method involves antagonistic interactions between CP110, Cep97 and Klp10A at 
the distal end of centrioles (referred to as the Distal Tip Complex). Previous work in Drosophila 
has suggested that CP110 limits the centriolar microtubule depolymerizing activity of Klp10A, 
preventing over-shortening and maintaining the centriole at the correct length. However, how it 
does so mechanistically is unknown. Even less is known about the activity of centriolar protein 
Cep97 although previous work proposed it might have a stabilizing role on CP110. Using 
Drosophila Schneider 2 cells, we investigated the interaction of Cep97 and CP110. Our results 
suggest that Cep97, through a region in its C-terminal domain, binds and promotes the 
phosphorylation of CP110, bestowing stabilization.  
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Introduction 
Cancer and Genomic Instability 
Cancer is a disease that affects about one in five people worldwide, and accounts for one 
out of every six deaths (Bray et al., 2018). It is second only to heart disease as a leading cause of 
mortality and although it is largely a disease of aging, it is also the number one noncommunicable 
cause of death in children (Siegel et al., 2018). The term “cancer” itself is broad, encompassing 
over one-hundred different diseases. There is immense variation between and among cancers of 
different types and thus each case should be treated individually (Fisher et al., 2013). However, 
identifying universal themes is important for early detection with the aim of preventing disease 
progression.  
Although cancer is a heterogenous group of diseases, all malignant neoplasms require 
acquisition of several specific phenotypic traits. These so-called “hallmarks” include mechanisms 
that increase autonomous survival, proliferation, tissue invasion, and evasion of cell death 
(Hanahan and Weinberg, 2011). Development of these characteristics through mutation is often 
thought of as a multi-step evolutionary process in which cells gradually accumulate single 
mutations that convey a growth or survival advantage allowing them to expand clonally and 
outcompete neighboring cells. However, the normal DNA mutation rate cannot completely explain 
the complex genome alterations observed in most cancer cells (Greaves and Maley, 2012). The 
diverse genomes of these cells are instead explained by genomic instability, a state in which cells 
have an increased rate of accumulating genetic mutations (Giam and Rancati, 2015). Genomic 
instability can be at both the nucleotide level (nucleotide instability) and chromosomal level 
(chromosomal instability), although nucleotide instability is mostly dependent on mutations in 
DNA repair genes and is less frequently seen (Garraway and Lander, 2013). Chromosomal 
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instability (CIN) results in large-scale alterations such as whole or partial chromosomal deletions, 
amplifications, inversions, and translocations and thus, excessive CIN is often lethal. However, it 
is thought that there is a certain tolerance of malignant cells for CIN and at an optimal level it 
promotes tumor progression through the accumulation of many mutations all at once (Andor et al., 
2017). This is supported by the finding that aneuploidy, one of the consequences of CIN, is found 
in about eighty percent of cancer cells (Knouse et al., 2017).  
Although it has been over a hundred years since aneuploidy, the cell state of having an 
abnormal number of chromosomes, has been proposed as a driver of tumorigenesis, only recently 
has there been direct evidence for its causal role. In 2007, Weaver et al. published a study in which 
they used mice heterozygous for a CENP-E null mutation (CENP-E+/-) to induce aneuploidy. 
CENP-E (centromere-associated protein-E) is a kinesin motor protein that is only active during 
mitosis and functions to maintain the interaction between chromosomes and the mitotic spindle. 
Due to its absence in interphase, reduced levels of CENP-E have shown to induce aneuploidy 
without any apparent confounding effects. After about 20 months, CENP-E+/- mice developed 
significantly more tumors (lymphomas and pulmonary adenomas) than control mice, indicating 
that aneuploidy is indeed a driver of tumorigenesis. Interestingly, they also found that aneuploidy 
acts to inhibit tumorigenesis in some cases (Weaver et al., 2007). One possible explanation to this 
could be that not all CIN-induced karyotypes produce oncogenic phenotypes. Knouse et al. (2017) 
came to this conclusion after analyzing cancer genome sequencing data from the Cancer Genome 
Atlas. After identifying several patterns of whole chromosomal gains or losses between and among 
cancer types, they speculated that under selective pressure, cells that have lost chromosomes 
carrying combinations with anti-tumorigenic effects and/or have gained chromosomes with genes 
that in general favor tumorigenesis will outcompete their neighboring cells and initiate tumor 
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development. Cells that are not so lucky and do not gain advantageous karyotypes are either 
weeded out by apoptosis or fail to compete with adjacent cells and are not perpetuated (Knouse et 
al., 2017).  
One of the main mechanisms implicated in promoting CIN is chromosome missegregation 
during mitosis (Giam and Rancati, 2015). For cells to divide into two viable daughter cells, bipolar 
spindle formation is vital to properly segregate the duplicated genome into each respective cell 
(Ganem et al., 2009). However, even with the formation of a bipolar spindle there can be errors 
that occur that disrupt proper segregation of sister chromatids. Normally, the spindle assembly 
checkpoint (SAC) ensures this proper segregation by detecting and promoting the correction of 
aberrant spindle attachments. In amphitelic (proper) attachments, those in which sister chromatids 
are attached to opposite spindle poles, the correct tension is applied to each chromatid and the SAC 
is satisfied allowing for anaphase onset (Lampson and Cheeseman, 2011). Monotelic and syntelic 
attachments are improper attachments detected by the SAC in which either only one chromatid is 
attached to the spindle microtubules (MTs) or when each chromatid is attached by MTs stemming 
from a single spindle pole, respectively. A single sister chromatid could also be attached by both 
poles of the spindle in what is called a merotelic attachment. This type of improper attachment is 
less likely to be detected by the SAC due to proper tension of each chromatid and is therefore a 
common cause of chromosome missegregation (Musacchio and Salmon, 2007). Centrosome 
amplification is one mechanism thought to increase the frequency of merotelic attachments and is 
thus an instigator of CIN (Ganem et al., 2009; Silkworth et al., 2009).  
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Centrosome Amplification and Chromosomal 
Instability 
Centrosomes are cytoplasmic organelles 
that function as the microtubule organizing centers 
(MTOCs) of most animal cells, nucleating and 
organizing the microtubule cytoskeleton. Their 
composition can be divided into two main 
components: the pericentriolar material (PCM), a 
highly ordered protein matrix that confers 
microtubule nucleating activity, and the centrioles, 
two tethered, cylindrically shaped structures that 
recruit the PCM and act as the duplicating agents of 
the organelle (Bettencourt-Dias and Glover, 2007; 
Lawo et al., 2012). During mitosis, two centrosomes 
are important to establish the bipolar spindle and 
maintain the fidelity of chromosome segregation 
(Bettencourt-Dias et al., 2005). Cells with more 
than two centrosomes (i.e. centrosome 
amplification) have been shown to produce 
multipolar spindles in mitosis in which an increased 
frequency of merotelic attachments are made. In 
these cases, cells undergo centrosome clustering to 
produce a pseudo-bipolar spindle prior to anaphase 
Figure 1. Schematic representation of the mechanism by which 
multipolarity can lead to merotelic kinetochore attachment 
and mitotic chromosome mis-segregation. A. Within a 
multipolar spindle, a single kinetochore is more likely to face 
two spindle poles than it would be in a bipolar spindle. B. 
Because of the multipolar spindle geometry, a single 
kinetochore can easily bind microtubules emanating from two 
spindle poles rather than from just one pole. After 
establishment of merotelic kinetochore attachment, the 
mitotic spindle bi-polarizes by a process of spindle pole 
coalescence (or centrosome clustering). C. Merotelic 
kinetochore attachment can persist through metaphase and 
into anaphase. D. During anaphase, the merotelic kinetochore 
attachment can give rise to a lagging chromosome. From 
Silkworth, W.T., I.K. Nardi, L.M. Scholl, and D. Cimini. 2009. 
Multipolar spindle pole coalescence is a major source of 
kinetochore mis-attachment and chromosome mis-
segregation in cancer cells. PLoS One. 4:e6564. Creative 
Commons License: 
http://creativecommons.org/licenses/by/4.0/ 
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onset (Figure 1)(Quintyne et al., 2005).  Although this often results in viable cells, the merotelic 
attachments established earlier in mitosis are frequently left uncorrected and can lead to 
missegregation of  lagging chromosomes (Ganem et al., 2009; Silkworth et al., 2009). To challenge 
this in vivo, Levine et al. (2017) used transgenic mouse models with inducible expression of Plk4, 
a kinase important in centriole duplication and, when overexpressed, leads to centrosome 
amplification. They showed that induction of Plk4 overexpression lead to spontaneous tumor 
development in the form of lymphomas, squamous cell carcinomas, and sarcomas, indicating a 
causal role for centrosome amplification in tumorigenesis. Importantly, they showed that both 
chronic and transient Plk4 overexpression lead to tumor formation, isolating the role of centrosome 
amplification from indirect effects of constitutive Plk4 activity. This and several other organoid 
and animal models support the causal role of centrosome amplification in tumor initiation (Basto 
et al., 2008; Duensing et al., 2001a; Duensing et al., 2001b; Godinho et al., 2014; Goepfert et al., 
2002; Shono et al., 2001). Because centrosome amplification seems to be an early event in the 
progression of many cancers, it is crucial to elucidate the molecular mechanisms in order to gain 
a better understanding of the disease as a whole and to develop effective therapies (Godinho and 
Pellman, 2014). A closer look into the structure and biogenesis of centrioles (and the dysregulation 
thereof) is necessary to provide key insights into the process of centrosome amplification.  
Centriole Structure and Biogenesis 
As mentioned earlier, centrioles are cylindrical structures that make up centrosomes, 
however, they are not exclusively a centrosomal constituent. They also make up the basal body of 
cilia and flagella, two microtubule-composed cellular appendages important in a variety of vital 
cell functions such as motility, cell signaling, and sensory perception (Bettencourt-Dias and 
Glover, 2007). Centrioles are made up of stable, modified microtubules, arranged in a nine-fold 
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radial symmetry that is imparted by a structure called the cartwheel. Stacks of nine rod-shaped 
Sas6 protein homodimers radiating from their N-terminal contacts, form the “hub” and “spokes” 
of one tier of often a many-layered cartwheel (van Breugel et al., 2011). Although their size and 
structure can vary between species and tissues within a species, centriole morphology is relatively 
well-conserved. Chlamydomonas reinhardtii (green algae), Drosophila melanogaster (fruit flies), 
Caenorhabditis elegans (roundworms), and human cell lines are the four principal centriole model 
systems due to their many commonalities in regulation and structure (Figure 2)(Kitagawa and 
Gupta, 2018). Some of the main structural differences between the centrioles in these organisms 
are the length of the cartwheel (absent in human mother centrioles), the length the microtubules 
grow past the distal end of the cartwheel (flush with the cartwheel in somatic Drosophila cells), 
and the number of microtubule sets attached to the cartwheel spokes. The regulatory mechanisms 
that control these discrepancies is still under investigation, but much has been revealed in the past 
several decades.   
The biogenesis of centrioles can be accomplished by semi-conservative duplication of pre-
existing centrioles, by deuterosome formation, or by de novo assembly. The former is the canonical 
method and the one in which will be described hereafter, while the others occur in multiciliated 
cells or in the absence of a pre-existing centriole, respectively (Gönczy and Hatzopoulos, 2019). 
Centriole duplication in this way produces three distinct generations of centrioles: a grandmother, 
mother, and daughter. A nascent centriole growing off its mother is termed the “procentriole” but 
becomes the “daughter” when fully mature. In the next cycle, these centrioles are both used for 
duplication and are thus both “mothers”. The older of the two is often referred to as the 
“grandmother”  although its function is the same as the other mother, however distinction may be 
important in the context of disease (Yamashita et al., 2007).  
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Figure 2. A comparison of centriole structures across common model organisms. Schematic illustrations of centrioles and basal 
bodies of (A) Chlamydomonas, (B) human cells, (C) Drosophila, and (D) C. elegans. (A, B) Cartwheels are depicted in yellow, 
centriolar microtubules in purple, the pinhead connecting the cartwheel to the microtubules in blue and the A–C linker in green. 
Distal and subdistal appendages are not shown in this representation. A-, B-, and C-tubules are indicated on the longitudinal and 
cross-sections of the centrioles. Note that centriolar microtubules exhibit an anticlockwise twist as seen from the proximal end, 
and a clockwise twist as seen from the distal end, indicated by the directionality of the curved arrows. (C) Drosophila centrioles 
consist of several cartwheel stacks (yellow) surrounded by doublet microtubules in somatic cells (top, purple) or triplet 
microtubules in primary spermatocytes (bottom, purple). Electron–dense structures surrounding the cartwheel are indicated in 
light blue. CLR, cilium-like region. (D) C. elegans centrioles exhibit a smaller inner tube (yellow) concentric with a central tube 
(blue). Singlet microtubules (purple) are organized around the central tube, and electron–dense protrusions termed ‘paddles’ 
extend from each microtubule (light blue). The possible arrangement of cartwheel spokes is indicated as yellow dotted lines. All 
dimensions indicated are taken from published sources and the centrioles are depicted on the same scale to the extent possible.  
From Kitagawa, D., and A. Gupta. 2018. Ultrastructural diversity between centrioles of eukaryotes. The Journal of Biochemistry. 
164:1-8, by permission of Oxford University Press. 
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Centriole duplication is regulated by the cell cycle, one of its many similarities to DNA 
replication. Before centrioles can duplicate, they must first be “licensed” to do so. One part of 
licensing is the disengagement of centriole pairs from their tight configuration, mediated by 
separase and polo-like kinase 1 (PLK1). Separase is a well-known protease involved in the 
separation of sister chromatids during anaphase by cleavage of cohesion subunits, however, its 
activity is not as well-understood in centriole disengagement (Gönczy and Hatzopoulos, 2019). 
This disengagement is necessary for the formation of a procentriole but not sufficient for granting 
licensure. In humans, proteins Cep152 (Asterless in Drosophila), Cep57, and Cep63 form an 
isotropic complex around the mother centriole, which recruits Plk4 (Lukinavicius et al., 2013). 
Transient Plk4 activity, stabilized by SCL-interrupting locus protein (STIL) from ubiquitin-
mediated degradation, coordinates the single spot in which the procentriole will grow, limiting this 
event both to once per centriole and per cell cycle (Moyer et al., 2015; Rogers et al., 2009). The 
details of how this occurs is yet another ongoing area of research and will not be reviewed here. 
At the end of anaphase, Sas6 is recruited to the proximal centriole by STIL (Ana2 in Drosophila) 
to form the cartwheel, as described previously (Dzhindzhev et al., 2014). Visualization of live 
Drosophila embryos by structured illumination microscopy (SIM) revealed that Sas6 incorporates 
at the proximal end of the growing cartwheel. In the same study, Plk4 was shown to regulate both 
the rate and period of centriole growth, suggesting that it may control cartwheel length through 
Sas6 incorporation (Aydogan et al., 2018).  Although Sas6 can self-assemble into cartwheel-like 
structures in vitro, the fidelity of proper cartwheel assembly is increased with other centriole 
proteins such as Cep135 (Bld10 in Chlamydomonas). This protein localizes to the C-terminus of 
Sas6 homodimers in an electron dense region known as the pinhead (in humans) that is involved 
in anchoring microtubules to the cartwheel (Kraatz et al., 2016). Procentrioles begin to elongate in 
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S phase until they reach a certain length in late mitosis or early G1 (Nigg, 2007). How cells 
establish and regulate distinct centriole lengths is unclear, however there are several centriole-
related proteins that seem to be involved. Elucidation of mechanisms that govern centriole length 
is imperative as over-elongation of centrioles has been associated with tumorigenesis. 
Data from a recent study by Marteil et al. (2018) suggests that over-elongation of centrioles 
is a cause of chromosome segregation defects by inducing centriole amplification. This group 
looked at centriole numbers and length in the NCI-60 Human Tumor Cell Lines, a panel of cancer 
cell lines representative of clinically relevant human cancers from nine different tissues. In these 
cell lines they found significant increases in centriole number, centriole length, and heterogeneity 
of centriole length compared to non-transformed lines. After thoroughly validating their methods, 
they found that more than half of the cancer cell lines had significant centriole amplification (more 
than 4 centrioles in mitotic cells) compared to the control lines. Importantly, they found that 
centriole amplification was present in at least one cell line of each tissue type indicating that this 
phenomenon is not specific to certain tissues but is instead a widespread occurrence in tumors. 
Overly long centrioles were also found to be common in the NCI-60 panel and, notably, were 
associated with cell lines containing significant centrosome amplification. To test if overly long 
centrioles induced centrosome amplification, they overexpressed CPAP in cell lines with normal 
centriole numbers and lengths. It has been well established that overexpression of CPAP, without 
obvious indirect effects on centriole duplication, promotes centriole elongation—as was also found 
in this case (Kohlmaier et al., 2009). A significant percentage of mitotic cells had greater than four 
centrioles, indicating that over-elongation causes centriole amplification in these cell lines, 
corroborating findings from previous studies (Kohlmaier et al., 2009; Lin et al., 2013). As 
concurrent Plk4 overexpression did not suppress amplification in this setting, centriole 
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fragmentation was suspected. With transmission electron microscopy (TEM) and structured 
illumination microscopy (SIM) they were able to visualize fragments lacking STIL, indicating 
these were not newly formed procentrioles. This observation is not novel as fragment-like 
structures induced by overly long centrioles have been seen previously in both CPAP 
overexpression and, in Drosophila, inhibition of MT depolymerizing Kinesin-13, Klp10a 
(Delgehyr et al., 2012; Kohlmaier et al., 2009). However, Marteil and colleagues confirmed that 
these structures were in fact fragments (not procentrioles) not only in CPAP induced centriole 
elongation, but also found in the NCI-60 cell lines with centrosome amplification. On the other 
hand, this group also found cases in which STIL-positive centrioles were aberrantly attached along 
the length of an overly long centriole, suggesting that centriole amplification can also occur by 
ectopic procentriole formation. As it has been previously suggested that centriole length controls 
centrosome size and even microtubule nucleating capacity, this group looked at overly long 
centrioles using NCI-60 cell lines without amplification. Their data indicated that increased 
centriole length does recruit more PCM and, as a consequence, has stronger microtubule nucleating 
capacity leading to increased chromosome segregation defects (Marteil et al., 2018). Overall, the 
findings from this study implicate three mechanisms of chromosomal instability by centriole over-
elongation: increased MT nucleating capacity, centrosome amplification by centriole 
fragmentation, and amplification by ectopic procentriole formation (Figure 3) which altogether 
underscore the importance of resolving mechanisms that govern centriole length. Interactions 
between centrosomal proteins Cep97, CP110 and Klp10A at the distal end of centrioles have been 
proposed as one such mechanism.  
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Regulation of Centriole Length by the Distal Tip Complex  
Evolutionarily conserved and vital for procentriole formation, CP110 localizes to the distal 
end of both mother and daughter centrioles in cycling cells where it forms a cap-like structure 
(Chen et al., 2002; Kleylein-Sohn et al., 2007). It has been suggested to have several functions in 
centriole biogenesis, yet its role as a suppressor of ciliogenesis is the prevailing topic of study. 
Removal of CP110 from the distal tip is required prior to ciliogenesis and thus its regulation has 
implications in many ciliopathies (Nigg and Raff, 2009). Surprisingly neglected in the literature, 
Figure 3. Cellular consequences of centriole length deregulation. In cancer cells, over elongated centrioles induce centriole amplification 
through centriole fragmentation and/or ectopic procentriole formation along the elongated centrioles. Elongated centrioles also generate 
larger MTOCs with a higher capacity to nucleate MTs that enhance chromosome instability during mitosis. Both scenarios could give rise to 
aneuploidy and might as well induce invasiveness, therefore centriole length deregulation might participate to tumour initiation and 
progression. From Marteil et al., 2018. Over-elongation of centrioles in cancer promotes centriole amplification and chromosome 
missegregation. Nature communications. 9:1258-1258. Under Creative Commons License: http://creativecommons.org/licenses/by/4.0/ 
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however, is its role in centriole length regulation. This oversight might be explained by the 
abundance/importance of cilia in mammalian tissues but in Drosophila and other centriole-
containing organisms where cilia aren’t as common, the other roles of CP110 are more apparent. 
Centrioles elongate through incorporation of αβ-tubulin heterodimers between the distal ends of 
their nine sets of growing microtubules and the CP110 cap, suggesting that CP110 might play 
some regulatory role (Kleylein-Sohn et al., 2007). Although depletion of CP110 in cycling human 
cells leads to overly long centrioles, it has been observed to cause decrease in centriole length in 
Drosophila (Delgehyr et al., 2012; Schmidt et al., 2009). The explanation for this discrepancy is 
unknown, however may be attributed to the increased complexity of the human system. Klp10A, 
a kinesin-13 that depolymerizes centriolar MTs, physically interacts with CP110 at the distal tip 
in Drosophila. Delgehyr et al. (2012) investigated this interaction and found that CP110 and 
Klp10A have antagonistic roles to regulate centriole length. While CP110 depletion makes 
centrioles shorter, Klp10A depletion leads to centriole elongation and fragmentation. CP110 and 
Klp10A codepletion results in overly long centrioles, suggesting that CP110 regulates centriole 
length by limiting the depolymerizing activity of Klp10A. Inhibition of Klp10A activity leads to 
over elongation of centrioles with or without the presence of CP110, suggesting that although 
CP110 and Klp10A do physically interact, this interaction is not required for Klp10A recruitment 
or Klp10A-mediated MT depolymerization (Delgehyr et al., 2012). Instead, Klp10A is thought to 
localize to centrioles independently due to previously established kinesin-13 microtubule binding 
ability (Tan et al., 2006). In contrast, CP110 activity and recruitment to the centriole is dependent 
on another protein: Cep97.  
In 2007, Spektor et al. used immunoaffinity purification and subsequent mass spectrometry 
data in human cell lines to identify CP110 binding partners and found Cep97, a previously 
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unidentified centrosome-specific protein. Using RNA interference (RNAi) they found that the 
Cep97-CP110 interaction is crucial for localization of both proteins to the centrosome. Depletion 
of Cep97 led to not only CP110 disappearance from centrosomes, but overall reduction of CP110 
protein levels, while depletion of CP110 did not largely influence total Cep97 levels in the cell. 
This indicates that Cep97 might act to stabilize CP110. Knockdown of both proteins individually 
produced the same phenotypes: increased monopolar and multipolar spindles, cytokinesis defects, 
and premature ciliogenesis (Spektor et al., 2007). The overall conclusion of this paper was that 
Cep97 and CP110 suppress a ciliogenesis program, however, using similar methods another group 
interpreted the long structures produced by Cep97 and/or CP110 knockdown as elongated 
centrioles (Schmidt et al., 2009). Together Klp10A, Cep97, and CP110 form a complex at the 
distal tip, henceforth referred to as the Distal Tip Complex (DTC), that is fundamental in regulating 
centriole length. Many questions remain regarding the details of how the DTC works at the 
molecular level, especially the role of Cep97. Aside from its collaboration with CP110, not much 
is known about the activity of this protein. We used Drosophila Schneider 2 (S2) cells to 
investigate the action of Cep97 on CP110 in a simple model without cilia to isolate the effects to 
centriole elongation.  
Results 
Cep97 stabilizes a modified population of CP110.  
As the DTC is important in centriole length regulation, it is important to investigate how the DTC 
itself is regulated. Because Cep97 depletion decreases CP110 levels but not vice versa, it is thought 
that its binding somehow stabilizes CP110. With this in mind, we predicted that overexpression of 
Cep97 would lead to increased CP110 levels. We generated GFP C-terminally tagged Cep97 and 
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V5 tagged CP110 constructs, co-transfected them into S2 
cells, and made whole cell lysate immunoblots with SDS-
PAGE. Compared to expression of just GFP and V5-CP110 
as a control, V5-CP110 levels were increased more than 
twofold when co-expressed with Cep97-GFP (Figure 4).  Not 
only did the quantity increase, but the V5-CP110 band had a 
noticeable band shift upward, indicating a population of V5-
CP110 with slightly higher mass (Figure 4, arrow). To 
confirm this band shift was real and not simply an artifact of 
overexpression, we made whole cell lysates to look at 
endogenous CP110 during Cep97 knockdown and in 
replacement (Cep97-GFP). Knockdown of Cep97 with RNAi 
collapsed the band shift seen in the presence of both 
endogenous and exogenous Cep97, confirming physiologic 
relevance of this pool of higher-mass CP110 (Figure 5). To 
confirm Cep97 truly has a stabilizing role, we treated V5-
CP110 and either GFP or Cep97-GFP expressing S2 cells 
with cycloheximide (an inhibitor of protein translation) and 
lysed cells every two hours for eight hours to observe CP110 
levels over time (Figure 6). In the GFP control, V5-CP110 
bands exhibited a continuous fading over the eight-hour time 
course, unlike in Cep97-GFP overexpression where protein 
levels stayed relatively stable until gradually tapering off 
Figure 4. Overexpression of Cep97-
GFP both increases V5-CP110 levels 
twofold and promotes a V5-CP110 
bandshift indicating higher molecular 
weight population of V5-CP110 
(arrow). Immunoblots of lysates were 
made from S2 cells expressing V5-
CP110 and either GFP (control) or 
Cep97-GFP and probed with anti-GFP, 
-V5, and -tubulin (loading control). 
 
Figure 5. Knockdown of Cep97 collapsed the 
band shift seen in the presence of both 
endogenous and exogenous Cep97. 
Immunoblots of cell lysates were made from S2 
cells transfected with or without Cep97 UTR 
dsRNA (RNAi) and either  GFP or Cep97-GFP 
and stained for anti-GFP, -CP110, -Cep97, and -
Tubulin (loading control). Low and high 
exposure images used to show both 
endogenous Cep97 (arrowheads) and 
exogenous Cep97-GFP (dots). 
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after four hours. Interestingly, the degradation seen in the control was especially pronounced in 
the topmost band whereas in Cep97 overexpression the entirety of V5-CP110 staining faded after 
eight hours, confirming that Cep97 stabilizes modified CP110. Also of note, Cep97-GFP levels 
(but not GFP) decreased in similar kinetics to V5-CP110 which could explain the degradation of 
V5-CP110. Cep97 could possibly be regulated by some unknown mechanism which ultimately 
controls CP110. Together, these data suggest the presence of Cep97 promotes the stabilization of 
a post-translationally modified pool of CP110. Our next objective was to determine which post-
translational modification was causing the CP110 band shift. 
Cep97 stabilizes phosphorylated CP110. 
Previous findings established that CP110 is a cyclin E/cyclin-dependent kinase 2 (CDK2) 
substrate which makes phosphorylation an attractive candidate for the Cep97 promoted CP110 
Figure 6. After treatment with cycloheximide, V5-CP110 levels when co-expressed with GFP degraded 
steadily over eight hours. V5-CP110 when co-expressed with Cep97-GFP stayed relatively constant but 
began to degrade after four hours somewhat in parallel to the Cep97 signal. S2 cells transfected with V5-
CP110 and either GFP or Cep97-GFP were treated with cycloheximide, then lysed at the time points 
indicated. Cell lysates were used to make western blots and probed with anti-V5, -GFP, -Tubulin (loading 
control).  
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band shift (Chen et al., 2002). To test if 
it is indeed phosphorylation, we used 
V5 targeted immunoprecipitation (IP) 
on S2 cell lysates expressing V5-
CP110 and either GFP, Cep97-GFP, or 
Klp10A-GFP and treated with and 
without lambda-phosphatase (Figure 
7). Consistent with previous findings, 
without lambda-phosphatase treatment 
V5-CP110 had a noticeably larger band 
shift up when co-transfected with 
Cep97-GFP than with GFP or Klp10A-
GFP (Figure 7, arrow). However, 
lambda-phosphatase treatment 
collapsed V5-CP110 bands in all 
conditions into a single lower band, confirming that the modification is in fact phosphorylation. 
Whether it is Cyclin E/CDK2 phosphorylation is unclear, however, moving forward this will be 
important to determine.  
Carboxy-terminal fragment of Cep97 imparts binding and stabilization of CP110. 
Previous work identified regions of CP110 (residues 1-223) and Cep97 (residues 300-750) 
necessary and sufficient for stable Cep97-CP110 binding in humans, however as we are using the 
Drosophila orthologs we identified functional domains within these sequences (Spektor et al., 
2007). To identify which region of Cep97 was responsible for binding CP110, we sectioned Cep97 
Figure 7. Treatment with lambda-phosphatase collapsed CP110 band 
shift stabilized by Cep97 (arrowhead).S2 cells were transfected with V5-
CP110 and either GFP, Cep97-GFP, or Klp10A-GFP and induced to 
express 24 hours after. Inputs were created from cell lysates while IP 
samples were prepared by anti-V5 immunoprecipitation from cell 
lysates and treated with or without lambda-phosphatase. Immunoblots 
were probed for GFP, V5, and α-tubulin.  
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into three distinct fragments: F1 (1-351), F2 
(352-513), and F3 (514-806). According to 
these fragments, we created C-terminally 
tagged Cep97 truncation mutants with and 
without each fragment, rendering seven 
distinct constructs including full-length 
Cep97 (FL). We co-expressed these 
constructs with V5-CP110 in S2 cells after 
RNAi induced knockdown of endogenous 
Cep97. Co-immunoprecipitation revealed 
Cep97 fragments containing F3 (FL, ΔF1, 
ΔF2, F3) were necessary and sufficient to 
pull down V5-CP110, indicating F3 is 
responsible for CP110 binding (Figure 8). Also, V5 inputs showed subtle but consistent CP110 
band shifts upward only when co-expressed with Cep97 constructs containing F3, indicating that 
within amino acids 514-806 of Cep97 is a domain that confers stabilization and binding of CP110. 
Whether these two features of Cep97-F3 are imparted by one or separate entities is unclear, and 
consequently two competing hypotheses emerge: Cep97 binds a pre-phosphorylated CP110 and 
blocks degradation or Cep97 binds CP110 and promotes the phosphorylation event leading to 
stabilization. Finding the phosphorylation site will be an important step moving forward as 
phosphomimetics could clarify this and other questions regarding the ability this modification 
bestows.  
Figure 8. F3 of Cep97 is necessary and sufficient for binding CP110 
and stabilizing specific phosphorylated CP110 pool. All and only 
constructs containing F3 (FL, ΔF1, ΔF2, F3) pulled down V5-CP110 
during immunoprecipitation. Cell lysates were created from S2 cells 
transfected with Cep97 UTR dsRNA, V5-CP110, and either GFP or 
the various Cep97 constructs. Anti-GFP Immunoprecipitation was 
used and immunoblots were stained with anti-GFP, -V5, and Tubulin 
antibodies.  
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Cep97 binding promotes phosphorylation of CP110.  
In humans, CP110 is ubiquitinated 
and sent for proteasomal degradation by 
SCFCyclin F and thus we suspected CP110 
would be degraded by the proteasome in 
Drosophila as well (D’Angiolella et al., 
2010). To test whether Cep97 activity was 
preventing CP110 from proteasomal 
degradation, we implemented proteasome 
inhibitor MG132 (Lee and Goldberg, 1998). 
We depleted Cep97 using RNAi in S2 cells 
then treated with MG132 or DMSO for five 
hours prior to lysing (Figure 9).  Immunoblots of cell lysates using antibodies against endogenous 
CP110 showed reversal of Cep97 knockdown-induced CP110 depletion with MG132 treatment 
compared to DMSO control, confirming proteasomal degradation of CP110 in Drosophila. These 
results also indicate that Cep97 does prevent CP110 degradation, however, the CP110 band seen 
after proteasomal inhibition with concurrent Cep97 depletion did not show the typical Cep97-
promoted phosphorylation. Compared to CP110 from cells transfected with control RNA (PET28a 
dsRNA) and treated with DMSO (representing the physiologic CP110 population), CP110 ran as 
a thinner band in the experimental condition (representing the population of CP110 that would 
have been degraded without Cep97). This suggests that Cep97 does not bind and stabilize 
phosphorylated CP110 but instead plays a role in promoting phosphorylation.  
 
Figure 9. Drosophila CP110 is stabilized by proteasome inhibitor 
MG132. MG132 rescues Cep97 knockdown induced collapse of 
CP110 band shift. S2 cells were treated with either Ctrl (PET28a) or 
Cep97 UTR dsRNA for 6 days. On the 7th day cells were either 
treated with DMSO (control) or MG132 and incubated for 5 hours 
prior to lysing. Immunoblots of samples were stained with anti-
CP110, -Cep97, and -Tubulin (loading control).  
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Discussion 
Many questions remain about the mechanism of which Cep97 stabilizes CP110, including 
how Cep97 promotes phosphorylation. To seek the answer of this, finding the kinase responsible 
will be important. As mentioned earlier, CP110 is a CycE/CDK2 substrate, although it is unknown 
whether this complex is accountable for all of CP110 phosphorylation (Chen et al., 2002). Further 
experimentation would be important to identify if CDK2 was responsible for this Cep97 
stabilization specific phosphorylation. Another crucial discovery will be the mechanism by which 
this phosphorylation stabilizes CP110 levels. One possibility could be the phosphorylation-
dependent recruitment or binding of a deubiquitinating enzyme (DUB) that removes constitutive 
ubiquitination. In 2013, Li et al. identified a DUB, USP33, that stabilizes CP110 levels during 
centriole duplication in human cells. The same has yet to be reported in Drosophila, however, 
there is a protein that shares homology. Identification of both the phosphorylation site and 
ubiquitin site could yield more insight. CP110 localizes to both the mother and daughter centriole 
during the cell cycle, but because the mother centriole maintains its length throughout there may 
be a mechanism involving dissimilar CP110 phosphorylation states at the two sites. It would be of 
interest to identify the spatial differences of varying phospho-CP110 pools.  
In conclusion, our data suggests that Cep97, through fragment three in its C-terminal 
domain, binds and promotes the phosphorylation and stabilization of CP110. This allows CP110 
to localize to the distal tip of the centriole and interact with Klp10A, regulating centriole length. 
Dysregulation of the interactions of the DTC can lead to centriole elongation, which through 
fragmentation and procentriole formation can cause centrosome amplification. Understanding the 
underlying mechanisms of centrosome amplification is crucial as it is known to cause genomic 
instability, one of the hallmarks of cancer.  
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Materials and Methods 
Drosophila cell culture 
Drosophila S2 cell culture was performed as previously described (Rogers and Rogers, 2008). S2 
cells (Life Technologies; catalogue no. R69007) were cultured at room temperature (20–25°C) in 
Sf900II SFM medium (Life Technologies; catalogue no. 10902104).  
 
Double-stranded RNA (dsRNA) interference 
dsRNA interference (RNAi) was performed as previously described (Rogers and Rogers, 2008). 
Briefly, cells were cultured in six-well plates at 50–90% confluency in 1 ml of medium. Cells were 
treated with 10 μg dsRNA every day for 5-7 d. Control dsRNA was synthesized from noncoding 
DNA in a pET28a vector template (Clontech) using the primers 5′-ATCAG GCGCTCTTCCGC 
and 5′-GTTCGTGCACACAGCCC. Generated a Cep97 5'-3' UTR fusion construct by 
mutagenizing to delete coding region from EST using the following primers: 97Fus-1: 
CGGCCTGCCAATCAGAAAAACAAATCCCAGTTAATAAATGAGGAGTATAAACGCT 
TTAAGGGTCG and 97Fus-2: CGACCCTTAAAGCGTTTATACTCCTCATTTATTAACTGG 
GATTTGTTTTTCTGATTGGCAGGCCG. T7 Template was generated from 5'-3' UTR fusion 
through PCR amplification using primers: 97UTRT7-F: TAATACGACTCACTATAGGG 
GTCGAGAGCGGAGACG and 97UTRT7-R: TAATACGACTCACTATAGGG 
ACTATTGTTAAGTCTTCCACCATCGC. 
 
Immunoblotting 
S2 cell lysates were produced by lysing cells in cold PBS containing 0.1% Triton X-100. Laemmli 
sample buffer was then added and the samples were boiled for 5 min. Samples of equal total protein 
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were resolved by SDS–PAGE, blotted, probed with primary and secondary antibodies, and 
scanned on an Odyssey imager (Li-Cor Biosciences). Care was taken to avoid saturating the scans 
of blots. Antibodies used for Western blotting include chicken anti-Cep97 (our laboratory), guinea 
pig anti-CP110 (our laboratory), mouse anti-GFP monoclonal JL-8 (Clontech; catalogue no. 
632380), mouse anti-V5 monoclonal (Life Technologies; catalogue no. R960-25), and mouse anti-
a tubulin (Sigma-Aldrich; catalogue no. T9026) at dilutions ranging from 1:1000 to 1:3000. IRDye 
800CW secondary antibodies (Li-Cor Biosciences) were prepared according to manufacturer’s 
instructions and used at dilutions ranging from 1:1500 to 1:3000 dilution.  
 
Constructs and transfection  
FL cDNAs of Drosophila CP110, Cep97, Klp10A were subcloned into a pMT vector containing 
in-frame coding sequences for EGFP or V5 under control of the inducible metallothionein 
promoter. Mutants of Cep97 were generated by PCR-based site directed mutagenesis with Phusion 
polymerase (ThermoFisher; catalogue no. F530S). For transient transfections, (2–5) × 106 S2 cells 
were pelleted by centrifugation and resuspended in 100 μl of transfection solution (5 mM KCl, 15 
mM MgCl2, 120 mM sodium phosphate, 50 mM d-mannitol, pH 7.2) containing 2 μg of purified 
plasmid. The resuspension was then transferred to a 2-mm gap cuvette and electroporated using a 
Nucleofector 2b (Lonza), program G-030. Transfected cells were immediately diluted in 1 ml of 
SF-900 II medium and placed in a six-well tissue culture plate. Cells were typically allowed to 
recover for ∼24 h before inducing by the addition of 0.5–2 mM CuSO4 to the culture medium. For 
cycloheximide assay, 100 ug/mL cycloheximide (Sigma) was added to 5 wells of each condition 
at time 0. A single well of each condition was lysed at 0, 2, 4, 6, and 8 hours. Band intensities were 
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quantified using ImageJ and normalized to tubulin load, values are compared to normalized 
intensity at Time 0. 
 
Immunoprecipitation assays 
GFP-binding protein (GBP)(Rothbauer et al., 2008) was fused to the Fc domain of human IgG 
(pIg-Tail; R&D Systems), tagged with His6 in pET28a (EMD Biosciences), expressed in 
Escherichia coli, and purified on HisPur resin (ThermoFisher; catalogue no. 88221) as described 
previously (Buster et al., 2013). Purified GBP was bound to magnetic Dyna Beads (ThermoFisher; 
catalogue no. 10001D), and then cross-linked to the resin by incubating with 20 mM dimethyl 
pimelimidate dihydrochloride in PBS, pH 8.3, 2 h at 22°C, then quenched by incubation with 0.2 
M ethanolamine, pH 8.3, 1 h at 22°C. Antibody-coated beads were washed three times with 
PBSTween20 (0.02%), then equilibrated in 1.0 ml of cell lysis buffer (CLB; 50 mM Tris, pH 7.2, 
125 mM NaCl, 2 mM DTT, 0.1% Triton X-100, and 0.1 mM phenylmethylsulfonyl fluoride 
[PMSF]). Transfected cells expressing recombinant proteins were lysed in CLB, and the lysates 
clarified by centrifugation at 16,100 × g for 5 min at 4°C. Inputs (0.5–1%) were used for 
immunoblots. GBP-coated beads were rocked with lysate for 30 min at 4°C, washed three times 
with 1 ml CLB, and then boiled in Laemmli sample buffer.  
For V5-immunoprecipitation anti-V5 antibodies (Invitrogen) were coupled to Protein G 
Dynabeads (Invitrogen). IP protocol was as described for GFP. Final IPs were split in half and 
incubated at 30C for 30 minutes in phosphatase buffer (NEB) + 20 mM MnCl2 with or without 
lambda phosphatase (housemade), buffer was removed, then IP was eluted as normal.  
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